Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.
B. Svensson, A. Boonen, K. Albertsson, D. M. van der Heijde +2 more
2005Arthritis & Rheumatism363 citations
Semantic Scholar

